Health ❯ Pharmaceuticals

Drug Regulation

FDA Quality Control GLP-1 Drugs FDA Decisions Counterfeit Drugs Public Health FDA Approvals Enforcement Actions Weight Loss Drugs FDA Actions

FDA Approves Colorado Plan to Import 20 Prescription Drugs From Canada

The decision could cut costs for patients but imports cannot begin until Colorado secures suppliers and completes FDA-mandated batch testing.

ImmunityBio Investors Face May 26 Lead-Plaintiff Deadline in Securities Suit Tied to FDA Anktiva Rebuke

Appeals Court Halts Mail Delivery of Abortion Pill Mifepristone Nationwide

Telangana Drug Regulator Flags 75 Pharmacies in GLP-1 Sales Crackdown

Gurugram Bust Exposes Counterfeit Mounjaro Operation With Suspected China Link

India Tightens Oversight of GLP-1 Diabetes and Weight-Loss Drugs

India Tightens Oversight as Low‑Cost Semaglutide Hits Pharmacies

India’s Drug Regulator Flags 90 Unapproved Fixed-Dose Medicines, Orders State Probes

DCA Seizes ₹8 Lakh in Drugs, Uncovers Alleged Label Tampering in NTR District

ANMAT Cancels Authorizations for More Than 60 Drug Distributors Over Expired Certificates

ANMAT Bans Imported Tide Detergent Over Labeling Breaches, Orders Recall and Sanitary Probe

Hims & Hers Halts $49 Compounded Wegovy Pill as FDA Tightens GLP-1 Rules

Cofepris Issues January 20–21 Health Alerts on Counterfeit Entresto and Illegally Sold Products in Mexico

FDA Seeks Removal of Suicide Warnings From Saxenda, Wegovy and Zepbound

Argentina Names Luis Fontana to Lead ANMAT After Fentanyl Scandal

Anvisa Bans Sales and Advertising of Raia Drogasil’s Needs and Bwell Medicines

Legal Bid Seeks to Halt UK Puberty‑Blocker Trial Approved by Regulators

Maharashtra Cancels 215 Pharmacy Licences After Tests Expose Widespread Substandard Drugs

FDA Installs Tracy Beth Hoeg as Acting CDER Director as Pazdur Files Retirement

India Orders Immediate Drug Plant Inspections, Sets January 2026 GMP Deadline